The diabetic brain and cognition

P Riederer, AD Korczyn, SS Ali, O Bajenaru… - Journal of neural …, 2017 - Springer
The prevalence of both Alzheimer's disease (AD) and vascular dementia (VaD) is increasing
with the aging of the population. Studies from the last several years have shown that people …

[HTML][HTML] Metformin: the winding path from understanding its molecular mechanisms to proving therapeutic benefits in neurodegenerative disorders

LM Isop, AE Neculau, RD Necula, C Kakucs, MA Moga… - Pharmaceuticals, 2023 - mdpi.com
Metformin, a widely prescribed medication for type 2 diabetes, has garnered increasing
attention for its potential neuroprotective properties due to the growing demand for …

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease

A Knezovic, J Osmanovic-Barilar, M Curlin… - Journal of neural …, 2015 - Springer
Sporadic Alzheimer's disease (sAD) is the most common form of dementia. Rats injected
intracerebroventricularly with streptozotocin (STZ-icv) develop insulin-resistant brain state …

Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease

I Kazkayasi, G Telli, E Nemutlu, S Uma - Life Sciences, 2022 - Elsevier
Aims The relationship between type 2 diabetes and Alzheimer's disease (AD) provides
evidence that insulin and insulin sensitizers may be beneficial for the treatment of AD. The …

From attention-deficit hyperactivity disorder to sporadic Alzheimer's disease—Wnt/mTOR pathways hypothesis

E Grünblatt, J Homolak, A Babic Perhoc… - Frontiers in …, 2023 - frontiersin.org
Alzheimer's disease (AD) is the most common neurodegenerative disorder with the majority
of patients classified as sporadic AD (sAD), in which etiopathogenesis remains unresolved …

Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment …

N Rajasekar, C Nath, K Hanif, R Shukla - Molecular neurobiology, 2017 - Springer
Alzheimer's disease (AD) is associated with reduced insulin level and impairment of insulin
receptor (IR) signaling in the brain, which correlates to amyloid pathology …

Performance of the intracerebroventricularly injected streptozotocin Alzheimer's disease model in a translationally relevant, aged and experienced rat population

A Gáspár, B Hutka, AJ Ernyey, BT Tajti, BT Varga… - Scientific Reports, 2022 - nature.com
The intracerebroventricularly (icv) injected streptozotocin (STZ) induced brain state is a
widely used model of sporadic Alzheimer-disease (AD). However, data have been …

Anandamide effects in a streptozotocin-induced Alzheimer's disease-like sporadic dementia in rats

D Moreira-Silva, DC Carrettiero, ASA Oliveira… - Frontiers in …, 2018 - frontiersin.org
Alzheimer's disease (AD) is characterized by multiple cognitive deficits including memory
and sensorimotor gating impairments as a result of neuronal and synaptic loss. The …

Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease

MS Alavi, S Fanoudi, M Hosseini… - Metabolic Brain Disease, 2022 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder among the
elderly. In the light of increasing AD prevalence and lack of effective treatment, new …

Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive …

D Wang, L Liu, S Li, C Wang - Physiology & Behavior, 2018 - Elsevier
Paeoniflorin (PF) is a natural monoterpene glycoside in Paeonia lactiflora pall with anti-
diabetic, antioxidant, anti-inflammatory, and neuro-protective properties. This study was …